Organovo (ONVO) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free ONVO Stock Alerts $1.00 +0.01 (+1.01%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOrganovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 26 at 2:18 AMWhy Organovo Stock Is Up Todaymsn.com - April 15 at 2:40 PMOrganovo's fatty liver disease drug meets main goal in mid-stage studyreuters.com - April 15 at 8:28 AMOrganovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placeboglobenewswire.com - April 15 at 8:05 AMOrganovo Holdings Stock (NASDAQ:ONVO) Earnings Dates and Earning Callsbenzinga.com - February 24 at 7:35 AMOrganovo Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - February 10 at 2:25 PMOrganovo Holdings Inc ONVOmorningstar.com - February 9 at 7:39 PMONVO Continues Progressfinance.yahoo.com - February 9 at 2:38 PMOrganovo: Fiscal Q3 Earnings Snapshotsfgate.com - February 8 at 7:40 PMOrganovo Holdings Unveils Corporate Presentation Onlinemsn.com - February 8 at 9:38 AMOrganovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congressfinance.yahoo.com - January 25 at 12:43 PMOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congressfinance.yahoo.com - January 9 at 9:33 AMOrganovo, Inc.: Organovo Provides Timing for Release of FXR314 Phase 2 NASH Resultsfinanznachrichten.de - December 7 at 8:37 AMOrganovo Provides Timing for Release of FXR314 Phase 2 NASH Resultsfinance.yahoo.com - December 6 at 9:16 AMOVNO Continues Developing Breakthrough Treatmentsmsn.com - November 13 at 4:20 PMCORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Planfinance.yahoo.com - November 13 at 8:43 AMOrganovo Holdings Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.38 loss in 2Q 2023)finance.yahoo.com - November 11 at 9:02 AMOrganovo Highlights FXR314 Combination Therapy Potential and Planfinance.yahoo.com - November 8 at 12:13 PMONVO, FATH and BYU among mid-day moversmsn.com - November 7 at 3:44 PMONVO: A Company With Great Technology to Impact Health Carefinance.yahoo.com - October 10 at 12:56 PMOrganovo to Participate in the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - September 8 at 4:06 PMIs Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trapfinance.yahoo.com - August 25 at 11:10 PMOrganovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Datafinance.yahoo.com - August 23 at 8:32 AMOnvo receives $3 million grant from PennDOT to enhance electric vehicle charging infrastructuremsn.com - August 16 at 4:07 PMONVO Organovo Holdings, Inc.seekingalpha.com - July 29 at 11:40 PMOnvo introduces first public fast electric vehicle chargers on I-81 stretchmsn.com - July 20 at 11:48 AMOrganovo (NASDAQ: ONVO)fool.com - June 7 at 8:56 AMOrganovo Announces FXR Programfinance.yahoo.com - March 21 at 9:27 AMWill Organovo Holdings (NASDAQ:ONVO) Spend Its Cash Wisely?finance.yahoo.com - February 10 at 8:02 AMOrganovo Holdings, Inc. (ONVO)finance.yahoo.com - October 25 at 2:20 PMTrends in 3D-Printing Materials Technology and the Global Market for the Most Promising New 3D-Printing Materials Applications - Yahoo Financefinance.yahoo.com - October 17 at 6:23 PMHuman Liver Models Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | D - Benzingabenzinga.com - October 12 at 8:11 AM3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market - GlobeNewswireglobenewswire.com - October 9 at 7:51 PMARKG: Too Hard To Pin Down, Too Volatile For Comfort (BATS:ARKG) - Seeking Alphaseekingalpha.com - October 3 at 10:14 PMGlobal Laboratory Animal Models, 3D Cultures and Organoids Markets, 2019-2021 & 2022-2027 - Opportunities in Organoids in Drug Development, Personalized Medicine and Transplantational Medicine - PR Newswireprnewswire.com - September 30 at 12:25 PMGlobal Human Liver Model Market Report 2022: Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro Fuel Growth - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 30 at 12:25 PM3D Bioprinting Global Market Report 2022: Long-term Forecasts to 2026 & 2031 Featuring Organovo Holdings, Allevi, Cellink, Aspect Biosystems, & 3D Systems - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 29 at 4:15 PMWhy Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket - American Vir - Benzingabenzinga.com - September 23 at 9:58 AMWhy Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UKuk.investing.com - September 22 at 10:07 AMPre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - Nasdaqnasdaq.com - September 16 at 9:30 AMWhy Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UKuk.investing.com - September 16 at 9:30 AMPre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - RTTNewsrttnews.com - September 14 at 10:27 AMOrganovo to Participate in the H.C. Wainwright 24th Annual - GlobeNewswireglobenewswire.com - September 6 at 4:56 PMOrganovo Announces Postponement of Annual Meeting of Stockholders - GlobeNewswireglobenewswire.com - September 6 at 4:56 PMOrganovo Announces Postponement of Annual Meeting of Stockholdersfinance.yahoo.com - September 6 at 11:53 AMOrganovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 11:53 AM(AHI), (ALNA) – Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket - Benzingabenzinga.com - September 6 at 6:50 AMUSD 1.18 billion Growth in Human Organoids Market with 44% of the Contribution from North America - Technavio - Yahoo Financefinance.yahoo.com - September 5 at 10:47 AMIndustrial 3D Printing Market Expected to Reach $107.7 Billion By 2031: Allied Market Research - GlobeNewswireglobenewswire.com - August 30 at 9:19 PMGlobal 4D Printing Market is Predicted to Grow at a CAGR of ~40% during 2022-2031; Increasing Adoption of Novel 4D Printing in Biomedical Sciences such as Prostheses to Elevate Growth - Research Nester - Yahoo Financefinance.yahoo.com - August 12 at 4:24 PM Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ONVO Media Mentions By Week ONVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONVO News Sentiment▼0.360.32▲Average Medical News Sentiment ONVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONVO Articles This Week▼10▲ONVO Articles Average Week Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genetic Technologies News Today Sorrento Therapeutics News Today Coeptis Therapeutics News Today BioCardia News Today Senti Biosciences News Today Inhibikase Therapeutics News Today Creative Medical Technology News Today Titan Pharmaceuticals News Today Fresh Tracks Therapeutics News Today Palisade Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONVO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.